CEMACABTAGENE ANSEGEDLEUCEL

UNII:	W3X22HS7XD
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CEMACABTAGENE ANSEGEDLEUCEL
GSRS Full Record:	W3X22HS7XD i

Allogeneic T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis of healthy volunteer donors, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human CD19. The cells are also genetically modified using transcription activator-like (TAL) effector nucleases that are transiently delivered into the cell as mRNAs via electroporation and code for two pairs: one pair is designed for disruption of the T-cell receptor alpha constant (TRAC) and the other for disruption of the CD52 locus
Cemacabtagene Ansegedleucel
Cemacabtagene ansegedleucel [WHO-DD]
cemacabtagene ansegedleucel [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CEMACABTAGENE ANSEGEDLEUCEL

Synonyms and Mappings

Resources